In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Caremark will acquire AdvancePCS for $5.1bn in stock and cash

Executive Summary

Major pharmaceutical services company Caremark Rx has signed a definitive merger agreement to acquire AdvancePCS (health plan improvement products) for $5.1bn in cash, stock, and assumption of debt. The tax-free merger is expected to close next year, and will create a company with estimated combined annual revenues of $23bn.
Deal Industry
  • Pharmaceuticals
  • Services
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies